Download - B. Braun Space

In touch with the future
B. Braun Space GlucoseControl
Innovation
Today´s challenges
Need for intensive insulin treatment on ICU
Critically ill patients develop stress-induced hyperglycemia,
which is associated with adverse side effects and increases
the risk of mortality and morbidity.
How important is the treatment of
hyperglycemia in critically ill patients?
100
The importance to counteract has been revealed in a recent
inquiry of more than 800 ICU professionals [fig. 1].
Good news is that these risks can be minimized by intensive
insulin treatment as shown in several studies.1,2
However, normalization of blood glucose is a big challenge
increasing your workload: Being associated with an increased
risk of life-threatening hypoglycemia, the procedures for
blood glucose management are heterogeneous and complex,
demanding most accurate control.3,4
“Uncontrolled high blood glucose can lead to serious problems for
hospitalized patients,” ... “strategies must be identified to help
hospitals establish structured protocols for safe and effective management of blood glucose in both intensive care units and other
hospital settings.”
80
96.3 %
60
40
20
0
3.4 %
very important/important
fairly important/unimportant
Fig. 1: More than 95 % consider insulin therapy to be
important or very important for critically ill patients.
Recommendation of American Diabetes Association (ADA)
and American Association of Clinical Endocrinologists (AACE)
Insulin treatment in critically ill patients – a major need to meet
B. Braun Space GlucoseControl
Challenge accepted
B. Braun Space GlucoseControl realizes safe and reliable
glucose levels in critically ill patients with a significantly
reduced risk of hyper- and hypoglycemia.
With its intelligent dosage algorithm, the B. Braun Space
GlucoseControl integrates enteral and parenteral nutrition
and exactly determines insulin rate and next sampling
time – helping you to easily control complex work processes
for a safer future with minimized episodes of potentially
dangerous hyperglycemia and hypoglycemia.
B. Braun Space GlucoseControl – the solution to achieve safe
and reproducible blood glucose control
Two targets, one objective
Flexible selection between two glucose ranges
B. Braun Space GlucoseControl brings blood glucose to your desired targets
Strict Glucose Control
Moderate Glucose Control
Glucose (mmol/l)
20
Conventional Glucose Control
Glucose (mmol/l)
B. Braun Space
GlucoseControl
20
15
15
10
10
5
5
Conventional Glucose Control
Patient glucose
Moderate range
Patient glucose
Intensive range
Time (hours)
Strict Glucose Control within a range
of 4.4–6.1 mmol/l (80–110 mg/dl)
B. Braun Space
GlucoseControl
Time (hours)
Moderate Glucose Control within a range
of 4.4–8.3 mmol/l (80–150 mg/dl)
B. Braun Space GlucoseControl – two target ranges
to improve patient outcome
Get in touch with the future
B. Braun Space GlucoseControl integrates glucose management in your clinical routine
The decision support system for safe and reliable establishment of normal blood glucose
levels in critically ill patients.
Developed with the support of experienced intensive care physicians, nurses and biomedical engineers.
How does it work?
B. Braun GlucoseControl is integrated in the
B. Braun Space System with SpaceControl.
The touch screen of SpaceControl is a central
graphical user interface, which is connected
with the module containing the intelligent
learning algorithm.
The appropriate insulin rate is calculated
by the intelligent algorithm integrating all
important data:
latest blood glucose value
enteral nutrition
�
parenteral nutrition
�
history
�
patients’ weight
�
�
B. Braun Space GlucoseControl – more safety in daily
clinical workflow
Workflow in a new dimension
Actual improvement in your daily practice with Space
Automatic insulin application
1. Blood sampling
and analysis
3.Confirmation
of suggested
insulin rate
Automatic consideration
of nutrition data
Automatic calculation of
appropriate insulin rate and
next sampling time
2. Input of glucose value into SpaceControl
B. Braun Space GlucoseControl – optimized workflow
and simplified treatment decision for more safety in daily use
Reliability on a daily basis
B. Braun Space GlucoseControl in your clinical routine
The B. Braun Space GlucoseControl facilitates your workload in the treatment of
critically ill patients. Best guess decisions
are replaced by precise calculation of insulin rate and sampling time.
Patients benefit from optimized glucose
control and have less complications and
shorter stay time on ICU.
B. Braun Space GlucoseControl in your
intensive care environment – a decision
for the future.
B. Braun Space GlucoseControl more safety in daily clinical workflow
References
1 Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy
in critically ill patients. N Engl J Med 2001; 345:1359-67.
2 Van den Berghe G, Wilmer A, Hermans G et al. Intensive
insulin therapy in the medical ICU. N.Engl.J.Med. 2006; 354: 449-61.
3 Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and
pentastarch resuscitation in severe sepsis. N.Engl.J.Med. 2008; 358: 125-39.
4
Preiser J-C, Devos P, Ruiz-Santana S et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin
therapy in adult intensive care units: the Glucontrol study. Intensive Care
Med 2009; 35: 1738-1748.
B. Braun Melsungen AG | Hospital Care | 34209 Melsungen | Germany
Tel. +49 (0) 56 61 71-0 | www.bbraun.com
6069010